Staar Surgical: Hold Rating Amid Competitive Pressures and Strategic Initiatives
Canaccord Genuity analyst John Young CFA has maintained their neutral stance on STAA stock, giving a Hold rating yesterday.Stay Ahead of the ...
Staar Surgical (STAA) Receives a Buy from BTIG
BTIG analyst Ryan Zimmerman maintained a Buy rating on Staar Surgical (STAA – Research Report) today and set a price target of $39.00. The ...
Staar Surgical price target lowered to $39 from $49 at BTIG
BTIG lowered the firm’s price target on Staar Surgical (STAA) to $39 from $49 and keeps a Buy rating on the shares as part of ...
STAAR Surgical gains amid takeover speculation
STAAR Surgical (NASDAQ:STAA) rose 6.5% amid some takeover speculation. The maker of implantable lenses is said to have been ...
Hosted on MSN6mon
STAAR Surgical pares earlier gain amid takeover speculation, turns negative (update)
Update 3:35pm: Updates shares, adds STAAR surgical response. "We are very pleased with our momentum in 2024 and will provide an update on our performance on our 2Q earnings call in early August ...
news.stocktradersdaily12d
How the (STAA) price action is used to our Advantage
Type a few symbols and Take a Trial. The signals for these will appear immediately on your My Stocks Page; add more too.
CNN4y
STAAR Surgical Company
STAAR Surgical Co. engages in the design, development, manufacture, and sale of ophthalmic surgical products. The firm offers implantable lenses for the eye and accessory delivery systems.